Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Alpex Pharma is a Swiss-based pharmaceutical company specializing in advanced drug delivery systems, particularly orally dispersible tablets (ODTs) and effervescent tablets. The company operates as both an R&D innovator and contract manufacturer, offering end-to-end solutions from formulation development to global export. Their proprietary technologies enable improved patient compliance and product stability across multiple therapeutic areas including pain management, metabolic diseases, gastrointestinal disorders, respiratory health, nephrology support therapies, and more. With state-of-the-art GMP-compliant facilities in Switzerland covering approximately 7,000 square meters for both pharmaceutical and nutraceutical production lines, Alpex serves global clients with innovative dosage forms that address unmet medical needs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Alpex Pharma.